234 related articles for article (PubMed ID: 38172678)
1. Quantification of putative ovarian cancer serum protein biomarkers using a multiplexed targeted mass spectrometry assay.
Ryu J; Boylan KLM; Twigg CAI; Evans R; Skubitz APN; Thomas SN
Clin Proteomics; 2024 Jan; 21(1):1. PubMed ID: 38172678
[TBL] [Abstract][Full Text] [Related]
2. Novel Diagnostic Biomarkers for High-Grade Serous Ovarian Cancer Uncovered by Data-Independent Acquisition Mass Spectrometry.
Huh S; Kang C; Park JE; Nam D; Kim SI; Seol A; Choi K; Hwang D; Yu MH; Chung HH; Lee SW; Kang UB
J Proteome Res; 2022 Sep; 21(9):2146-2159. PubMed ID: 35939567
[TBL] [Abstract][Full Text] [Related]
3. Discovery and validation of serum glycoprotein biomarkers for high grade serous ovarian cancer.
Dutt M; Hartel G; Richards RS; Shah AK; Mohamed A; Apostolidou S; Gentry-Maharaj A; ; Hooper JD; Perrin LC; Menon U; Hill MM
Proteomics Clin Appl; 2023 Jul; 17(4):e2200114. PubMed ID: 37147936
[TBL] [Abstract][Full Text] [Related]
4. Screening by Q Exactive liquid chromatography/tandem mass spectrometry identified Choline, 25-hydroxyvitamin D2, and SM(d18:0/16:1(9Z) (OH)) as biomarkers for high-grade serous ovarian cancer.
Li J; Liu D; Cui M; Wei Z
J Proteomics; 2024 May; 299():105154. PubMed ID: 38471622
[TBL] [Abstract][Full Text] [Related]
5. Targeted Mass Spectrometry of Longitudinal Patient Sera Reveals LTBP1 as a Potential Surveillance Biomarker for High-Grade Serous Ovarian Carcinoma.
Wenk D; Khan S; Ignatchenko V; May T; Bernardini MQ; Kislinger T
J Proteome Res; 2024 Feb; 23(2):749-759. PubMed ID: 38266179
[TBL] [Abstract][Full Text] [Related]
6. Exosomal miR-1290 is a potential biomarker of high-grade serous ovarian carcinoma and can discriminate patients from those with malignancies of other histological types.
Kobayashi M; Sawada K; Nakamura K; Yoshimura A; Miyamoto M; Shimizu A; Ishida K; Nakatsuka E; Kodama M; Hashimoto K; Mabuchi S; Kimura T
J Ovarian Res; 2018 Sep; 11(1):81. PubMed ID: 30219071
[TBL] [Abstract][Full Text] [Related]
7. Multiplexed Targeted Mass Spectrometry-Based Assays for the Quantification of N-Linked Glycosite-Containing Peptides in Serum.
Thomas SN; Harlan R; Chen J; Aiyetan P; Liu Y; Sokoll LJ; Aebersold R; Chan DW; Zhang H
Anal Chem; 2015 Nov; 87(21):10830-8. PubMed ID: 26451657
[TBL] [Abstract][Full Text] [Related]
8. Protein isoform-specific validation defines multiple chloride intracellular channel and tropomyosin isoforms as serological biomarkers of ovarian cancer.
Tang HY; Beer LA; Tanyi JL; Zhang R; Liu Q; Speicher DW
J Proteomics; 2013 Aug; 89():165-78. PubMed ID: 23792823
[TBL] [Abstract][Full Text] [Related]
9. Circulating miRNA landscape identifies miR-1246 as promising diagnostic biomarker in high-grade serous ovarian carcinoma: A validation across two independent cohorts.
Todeschini P; Salviato E; Paracchini L; Ferracin M; Petrillo M; Zanotti L; Tognon G; Gambino A; Calura E; Caratti G; Martini P; Beltrame L; Maragoni L; Gallo D; Odicino FE; Sartori E; Scambia G; Negrini M; Ravaggi A; D'Incalci M; Marchini S; Bignotti E; Romualdi C
Cancer Lett; 2017 Mar; 388():320-327. PubMed ID: 28017893
[TBL] [Abstract][Full Text] [Related]
10. Multiplexed Immunoaffinity Enrichment of Peptides with Anti-peptide Antibodies and Quantification by Stable Isotope Dilution Multiple Reaction Monitoring Mass Spectrometry.
Kuhn E; Carr SA
Methods Mol Biol; 2016; 1410():135-67. PubMed ID: 26867743
[TBL] [Abstract][Full Text] [Related]
11. Integrated weighted gene co-expression network analysis reveals biomarkers associated with prognosis of high-grade serous ovarian cancer.
Wang B; Chao S; Guo B
J Clin Lab Anal; 2022 Feb; 36(2):e24165. PubMed ID: 34997982
[TBL] [Abstract][Full Text] [Related]
12. Data-Independent Acquisition and Parallel Reaction Monitoring Mass Spectrometry Identification of Serum Biomarkers for Ovarian Cancer.
Rauniyar N; Peng G; Lam TT; Zhao H; Mor G; Williams KR
Biomark Insights; 2017; 12():1177271917710948. PubMed ID: 28615921
[TBL] [Abstract][Full Text] [Related]
13. Proteomic Discovery of Plasma Protein Biomarkers and Development of Models Predicting Prognosis of High-Grade Serous Ovarian Carcinoma.
Kim SI; Hwangbo S; Dan K; Kim HS; Chung HH; Kim JW; Park NH; Song YS; Han D; Lee M
Mol Cell Proteomics; 2023 Mar; 22(3):100502. PubMed ID: 36669591
[TBL] [Abstract][Full Text] [Related]
14. Quantification of SAA1 and SAA2 in lung cancer plasma using the isotype-specific PRM assays.
Kim YJ; Gallien S; El-Khoury V; Goswami P; Sertamo K; Schlesser M; Berchem G; Domon B
Proteomics; 2015 Sep; 15(18):3116-25. PubMed ID: 26177823
[TBL] [Abstract][Full Text] [Related]
15. Discovery and Validation of Novel Protein Biomarkers in Ovarian Cancer Patient Urine.
Sandow JJ; Rainczuk A; Infusini G; Makanji M; Bilandzic M; Wilson AL; Fairweather N; Stanton PG; Garama D; Gough D; Jobling TW; Webb AI; Stephens AN
Proteomics Clin Appl; 2018 May; 12(3):e1700135. PubMed ID: 29426060
[TBL] [Abstract][Full Text] [Related]
16. Internal Standard Triggered-Parallel Reaction Monitoring Mass Spectrometry Enables Multiplexed Quantification of Candidate Biomarkers in Plasma.
Kennedy JJ; Whiteaker JR; Ivey RG; Burian A; Chowdhury S; Tsai CF; Liu T; Lin C; Murillo OD; Lundeen RA; Jones LA; Gafken PR; Longton G; Rodland KD; Skates SJ; Landua J; Wang P; Lewis MT; Paulovich AG
Anal Chem; 2022 Jul; 94(27):9540-9547. PubMed ID: 35767427
[TBL] [Abstract][Full Text] [Related]
17. Validation of a multiplexed LC-MS/MS clinical assay to quantify insulin-like growth factor-binding proteins in human serum and its application in a clinical study.
Liu N; Tengstrand E; Boernsen KO; Bek S; Hsieh F
Toxicol Appl Pharmacol; 2019 May; 371():74-83. PubMed ID: 30926377
[TBL] [Abstract][Full Text] [Related]
18. Profiling extracellular vesicles in circulation enables the early detection of ovarian cancer.
Jo A; Green A; Medina JE; Iyer S; Ohman AW; McCarthy ET; Reinhardt F; Gerton T; Demehin D; Mishra R; Kolin DL; Zheng H; Crum CP; Weinberg RA; Rueda BR; Castro CM; Dinulescu DM; Lee H
bioRxiv; 2023 Jan; ():. PubMed ID: 36711872
[TBL] [Abstract][Full Text] [Related]
19. Identification of serum miR-1246 and miR-150-5p as novel diagnostic biomarkers for high-grade serous ovarian cancer.
Niemira M; Erol A; Bielska A; Zeller A; Skwarska A; Chwialkowska K; Kuzmicki M; Szamatowicz J; Reszec J; Knapp P; Moniuszko M; Kretowski A
Sci Rep; 2023 Nov; 13(1):19287. PubMed ID: 37935712
[TBL] [Abstract][Full Text] [Related]
20. Targeted Protein Quantification Using Parallel Reaction Monitoring (PRM).
Barkovits K; Chen W; Kohl M; Bracht T
Methods Mol Biol; 2021; 2228():145-157. PubMed ID: 33950489
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
